Property Name | Property Value | Unit | Raw Value | Raw Unit | Reference |
---|---|---|---|---|---|
Log P | 3.22 | - | 3.22 | - | 'MSDS' |
Boiling Point | 777.5 | ℃ | 777.5 | ℃ | 'MSDS' |
Water Solubility | 1000.0 | mg/L | <1 | mg/ml | 'MSDS' |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Reference |
---|---|---|---|---|---|---|
AUC | 0.20 | ng.h/ml | 0.03-0.36 | ng.h/ml | DRUGBANK | |
C Max | 0.0850 | ng/ml | 0.02-0.15 | ng/ml | DRUGBANK | |
T Max | 0.50 | h | 0.48-0.51 | h | DRUGBANK | |
Tss | 168.0 | h | 7 | day | DRUGBANK | |
Volume of Distribution | 218.0 | L | 218.0 | L | intravenous injection, IV; | DRUGBANK |
Half-life | 46.2 | h | 22.3-70 | h | terminal half-life; | DRUGBANK |
Eliminate Route | 54.0 | % | 54 | % | Faeces excretion; intravenous injection, IV; | DRUGBANK | Eliminate Route | 27.0 | % | 27 | % | Urinary excretion; intravenous injection, IV; | DRUGBANK |
Protein Binding | 71.0 | % | 71 | % | plasma proteins; | DRUGBANK |
Property Name | Property Value | Unit | Raw Value | Raw Unit | Annotation | Brand Name | Component | Reference |
---|---|---|---|---|---|---|---|---|
Max dose for adults | 0.175 | mg/day | 175 | mcg/day | inhalation, IH | Yupelri | revefenacin | PDR |
Max dose for geriatric | 0.175 | mg/day | 175 | mcg/day | inhalation, IH | Yupelri | revefenacin | PDR |